Autopsy report · NCT05661669

Ketamine for the Treatment for Alcohol Use Disorder in the ED

“After months of screening, we screened 175 individuals, only 3 were eligible, 2 declined, and 1 was moved to a different floor before study activities were able to take place.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

Brigham and Women's Hospital

Sponsor type

University, hospital or other

Conditions

Alcohol Use Disorder

Interventions

Ketamine; Saline

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Pharmacologic Treatment in Legal Offenders With Schizophrenia, a Prospective Observational Mirror Image Study.
  “After screening, not enough participants fulfilled the inclusion criteria.” (68% match in meaning)
• Virtual Reality Exposure for Public Speaking Anxiety
  “Not enough of the screened participants met the inclusion criteria. Despite extensive recruitment efforts we could not recruit enough participants to reach the calculated target sample of 86 for randomization.” (64% match in meaning)
• The CIRCADIAN Study: Evaluation of Modulating Effect of Galantamine on Circadian Rhythm in Patients With Mild to Moderate Alzheimer's Disease
  “The recruitment rate was very low (one screening failure and one early withdrawal patient)” (59% match in meaning)
• Evaluation of the Effect of Psycho-oncological Intervention on Well-being of Patients With Advanced Prostate Cancer on LHRH Analogs and Their Partners. A Randomized Controlled Pilot Study.
  “Poor enrolment; only 6 subjects enrolled and they were all screen failures.” (57% match in meaning)
• Nab-paclitaxel Plus PD-1 Inhibitor Versus Nab-paclitaxel As Second-line Treatment in Advanced Gastric Cancer
  “slow recruitment forcing early suspension of screening and enrollment” (57% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.